Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

BACKGROUND: This case is the first report describing rapid, successful treatment of severe atopic dermatitis (AD) and comorbid type-2 inflammatory diseases in the same patient, with dupilumab treatment, with no side-effects. CASE PRESENTATION: We report on effects of dupilumab in a patient with seve...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Mol Allergy
Hlavní autoři: Nettis, Eustachio, Masciopinto, Lucia, Di Leo, Elisabetta, De Candia, Nicola, Albanesi, Marcello, Di Bona, Danilo, Quaranta, Nicola, Macchia, Luigi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207639/
https://ncbi.nlm.nih.gov/pubmed/34134707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12948-021-00144-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky